| Authors: |
Sanders JA; Department of Bioinformatics & Genomics, University of North Carolina at Charlotte, Charlotte, NC, USA.; Bioinformatics Services Division, University of North Carolina at Charlotte, Kannapolis, NC, USA., Frasier C; Department of Bioinformatics & Genomics, University of North Carolina at Charlotte, Charlotte, NC, USA.; Bioinformatics Services Division, University of North Carolina at Charlotte, Kannapolis, NC, USA., Matulay JT; Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA., Steuerwald NM; Molecular Biology and Microarray Core Facilities, Atrium Health, Charlotte, NC, USA., Zhu J; Department of Medical Oncology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA., Grigg CM; Department of Medical Oncology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA., Kearns JT; Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA., Riggs SB; Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA., Gaston KE; Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA., Brouwer CR; Department of Bioinformatics & Genomics, University of North Carolina at Charlotte, Charlotte, NC, USA.; Bioinformatics Services Division, University of North Carolina at Charlotte, Kannapolis, NC, USA., Burks RT; Carolinas Pathology, Charlotte, NC, USA., Hartman AL; Carolinas Pathology, Charlotte, NC, USA., Foureau DM; Immune Monitoring Core Laboratory, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA., Burgess EF; Department of Medical Oncology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA., Clark PE; Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA. |
